Department of Clinical Laboratory, The First Hospital of Jiaxing & The Affiliated Hospital of Jiaxing University, Jiaxing, China.
Blood Coagul Fibrinolysis. 2021 Sep 1;32(6):406-410. doi: 10.1097/MBC.0000000000001044.
The aim of this study was to elucidate the molecular defects of a Chinese family with hereditary coagulation factor XII (FXII) deficiency. The FXII activity (FXII:C) and FXII antigen (FXII:Ag) levels were measured by clotting assay and ELISA, respectively. To identify mutations, the F12 gene sequencing was carried out. ClustalX-2.1-win and four online bioinformatics tools were applied to study the conservatism and harm of the mutation. The proband's FXII:C and FXII:Ag were 3 and 4%, respectively. Sequencing analysis revealed compound heterozygous mutations, including the deletion mutation (c.130delG) resulting in p.E26Sfs∗50 and the missense mutation (c.1561G>A) resulting in p.E502K. Bioinformatics indicated that mutations probably disrupt the function of the FXII protein. The c.130delG heterozygous deletion variation and the c.1561G>A heterozygous missense variation were responsible for the reduction of FXII:C in this family, of which c.130delG was first reported in the world.
本研究旨在阐明一个具有遗传性凝血因子 XII (FXII) 缺乏症的中国家族的分子缺陷。通过凝血测定法和 ELISA 分别测定 FXII 活性 (FXII:C) 和 FXII 抗原 (FXII:Ag) 水平。为了鉴定突变,进行了 F12 基因测序。应用 ClustalX-2.1-win 和四个在线生物信息学工具来研究突变的保守性和危害性。先证者的 FXII:C 和 FXII:Ag 分别为 3%和 4%。测序分析显示复合杂合突变,包括导致 p.E26Sfs∗50 的缺失突变 (c.130delG) 和导致 p.E502K 的错义突变 (c.1561G>A)。生物信息学表明,突变可能会破坏 FXII 蛋白的功能。c.130delG 杂合缺失变异和 c.1561G>A 杂合错义变异导致该家族 FXII:C 的减少,其中 c.130delG 是首次在世界范围内报道的。